CIK 0001703647 · Non-accelerated filer<br>Smaller reporting company
Korro Bio, Inc.
Sign in to watch- Ticker
- KRRO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 472324450
- Phone
- 617-468-1999
- Business address
- 60 FIRST STREET, 2ND FLOOR, SUITE 250, CAMBRIDGE, MA, 02141
- Former names
- Frequency Therapeutics, Inc.
- Open-market buys, last 90 days
- $884,752
- in 1 filing
- Open-market sales, last 90 days
- $2,161,962
- in 6 filings, $2.2M under 10b5-1 plans
Net −$1,277,210. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-11 | Dolan Oliver Senior Vice President, Finance | Sale 10b5-1 | −5 | $13.72 | $69 | 16,241 |
| 2026-09-09 | Dolan Oliver Senior Vice President, Finance | Sale 10b5-1 | −6 | $13.60 | $82 | 16,246 |
| 2026-09-08 | Dolan Oliver Senior Vice President, Finance | Sale 10b5-1 | −7,347 | $13.51 | $99K | 16,252 |
| 2026-07-15 | Dolan Oliver Senior Vice President, Finance | Grant or award | +5,500 | 23,599 | ||
| 2026-06-16 | Dolan Oliver Senior Vice President, Finance | Sale | −3,383 | $10.83 | $37K | 18,099 |
| 2026-02-02 | Dolan Oliver Senior Vice President, Finance | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2025-12-15 | Dolan Oliver Senior Vice President, Finance | Grant or award | +21,482 | 21,482 | ||
| 2025-04-01 | Dolan Oliver Senior Vice President, Finance | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 |
Page 1 of 1 · 8 trades